Freudenberg Introduces HelixTC Sanitary Ends for Bioprocessing Applications

Expanded capabilities include overmolded components for biopharmaceutical fluid transfer assemblies

Freudenberg Medical, a manufacturer of medical and pharmaceutical devices, systems, components, and tubing, has introduced HelixTC™ overmolded sanitary ends in silicone for use in bioprocessing and single-use fluid transfer applications.

HelixTC is an alternative to standard barbed TC connections and is based on Freudenberg’s PharmaFocus® Premium product line of platinum-cured silicone tubing.

Available in standard or mini molded TC styles up to 1½ inch or 50mm OD and custom sizes or custom assemblies are available to order. The product comes with either stainless steel or polysulfone back-up cups.

“We are proud to launch our new HelixTC™ product line, which combines our extensive capabilities and expertise in tubing extrusion and injection molding,” states Rudi Gall, General Manager & Director Corporate Marketing at Freudenberg Medical. “With HelixTC™, which is designed around our well-proven silicone-based PharmaFocus® Premium tubing line, we extend our overall offerings to our pharmaceutical and biopharmaceutical customers. We are a true one-stop shop, making development and sourcing of products easier and faster for our customers. HelixTC™ is another example of how we aim to make life easier for our customers.”

Explore Freudenberg’s full line of biopharmaceutical products.

Visit us at these upcoming industry events – ISPE Boston Product Show, BioProcess International Conference & Exhibition, and CPhI India.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”